Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2018 2
2019 5
2020 6
2021 9
2022 4
2023 3
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

28 results

Results by year

Filters applied: . Clear all
Page 1
Masking the immunotoxicity of interleukin-12 by fusing it with a domain of its receptor via a tumour-protease-cleavable linker.
Mansurov A, Hosseinchi P, Chang K, Lauterbach AL, Gray LT, Alpar AT, Budina E, Slezak AJ, Kang S, Cao S, Solanki A, Gomes S, Williford JM, Swartz MA, Mendoza JL, Ishihara J, Hubbell JA. Mansurov A, et al. Nat Biomed Eng. 2022 Jul;6(7):819-829. doi: 10.1038/s41551-022-00888-0. Epub 2022 May 9. Nat Biomed Eng. 2022. PMID: 35534574
Pathogenic Exploitation of Lymphatic Vessels.
Magold AI, Swartz MA. Magold AI, et al. Cells. 2022 Mar 12;11(6):979. doi: 10.3390/cells11060979. Cells. 2022. PMID: 35326430 Free PMC article. Review.
Overcoming transport barriers to immunotherapy.
Yu SS, Hubbell JA, Swartz MA. Yu SS, et al. Drug Deliv Transl Res. 2021 Dec;11(6):2273-2275. doi: 10.1007/s13346-021-01084-4. Epub 2021 Oct 30. Drug Deliv Transl Res. 2021. PMID: 34718959 Free PMC article.
Engineering Targeting Materials for Therapeutic Cancer Vaccines.
Briquez PS, Hauert S, de Titta A, Gray LT, Alpar AT, Swartz MA, Hubbell JA. Briquez PS, et al. Front Bioeng Biotechnol. 2020 Feb 11;8:19. doi: 10.3389/fbioe.2020.00019. eCollection 2020. Front Bioeng Biotechnol. 2020. PMID: 32117911 Free PMC article. Review.
Membrane-localized neoantigens predict the efficacy of cancer immunotherapy.
Goldberger Z, Hauert S, Chang K, Kurtanich T, Alpar AT, Repond G, Wang Y, Gomes S, Krishnakumar R, Siddarth P, Swartz MA, Hubbell JA, Briquez PS. Goldberger Z, et al. Cell Rep Med. 2023 Aug 15;4(8):101145. doi: 10.1016/j.xcrm.2023.101145. Epub 2023 Aug 7. Cell Rep Med. 2023. PMID: 37552990 Free PMC article.
SARS-CoV-2 infection induces cross-reactive autoantibodies against angiotensin II.
Briquez PS, Rouhani SJ, Yu J, Pyzer AR, Trujillo J, Dugan HL, Stamper CT, Changrob S, Sperling AI, Wilson PC, Gajewski TF, Hubbell JA, Swartz MA. Briquez PS, et al. medRxiv [Preprint]. 2021 Nov 2:2021.11.02.21265789. doi: 10.1101/2021.11.02.21265789. medRxiv. 2021. PMID: 34751272 Free PMC article. Updated. Preprint.
Engineered IL-7 synergizes with IL-12 immunotherapy to prevent T cell exhaustion and promote memory without exacerbating toxicity.
Kang S, Mansurov A, Kurtanich T, Chun HR, Slezak AJ, Volpatti LR, Chang K, Wang T, Alpar AT, Refvik KC, Hansen OI, Borjas GJ, Shim HN, Hultgren KT, Gomes S, Solanki A, Ishihara J, Swartz MA, Hubbell JA. Kang S, et al. Sci Adv. 2023 Dec;9(48):eadh9879. doi: 10.1126/sciadv.adh9879. Epub 2023 Nov 29. Sci Adv. 2023. PMID: 38019919 Free PMC article.
28 results